Lorem ipsum dolor sit amet, consectetur adipiscing elit. In vitae neque varius, convallis felis non, sagittis velit. Vestibulum non tempor urna. Mauris venenatis arcu ligula. Vestibulum ante ipsum primis […]
Mediclin Laboratories
Investor Relations
Learn more about our company in the stock market
What’s New
Latest News
Alcoholic Cardiomyopathy
The focus of this review is on the effects of alcohol on the myocardium and its role as a cause of heart failure due to dilated cardiomyopathy (DC). For nearly 150 […]
Antidysrhythmic Toxicity
Antidysrhythmic medications are widely used to treat or prevent abnormalities in cardiac rhythms. They accomplish this through a number of mechanisms involving automaticity or ion channel dynamics, which in […]
Important
Sec Fillings
-
Core Lab Reports Second-Quarter 2020 Results
-
Core Lab Announces Q3 2020 Quarterly Dividend
-
Core Lab Announces Amendment to Revolving Credit Facility; Further Expansion of Cost Reduction Initiatives; Second Quarter 2020 Earnings Webcast at 7:30 A.M. CDT / 2:30 P.M. CEST on 23 July 2020
-
Core Lab Announces Results of its 2020 Annual Shareholder Meeting
-
Core Lab Announces Q2 2020 Quarterly Dividend